Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models

BACKGROUND: A tetravalent live attenuated dengue vaccine, Dengvaxia, sensitised naïve recipients to severe dengue illness upon a subsequent natural dengue infection and is suspected to be due to antibody-dependent enhancement (ADE). ADE has also been implicated in the severe neurological outcomes of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:EBioMedicine
Autors principals: Shukla, Rahul, Beesetti, Hemalatha, Brown, Julia A., Ahuja, Richa, Ramasamy, Viswanathan, Shanmugam, Rajgokul K., Poddar, Ankur, Batra, Gaurav, Krammer, Florian, Lim, Jean K., Kale, Sachin, Lal, Altaf A., Swaminathan, Sathyamangalam, Khanna, Navin
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7501058/
https://ncbi.nlm.nih.gov/pubmed/32949997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.102991
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars